-
Something wrong with this record ?
Dual Effects of Beta-Hydroxy-Beta-Methylbutyrate (HMB) on Amino Acid, Energy, and Protein Metabolism in the Liver and Muscles of Rats with Streptozotocin-Induced Type 1 Diabetes
M. Holeček, M. Vodeničarovová, R. Fingrová
Language English Country Switzerland
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
PROGRES Q40/02
Charles University
NLK
Directory of Open Access Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
PubMed
33114049
DOI
10.3390/biom10111475
Knihovny.cz E-resources
- MeSH
- Amino Acids administration & dosage pharmacology MeSH
- Diabetes Mellitus, Type 1 chemically induced drug therapy metabolism MeSH
- Injections, Intraperitoneal MeSH
- Injections, Subcutaneous MeSH
- Liver drug effects metabolism MeSH
- Muscle, Skeletal drug effects metabolism MeSH
- Rats MeSH
- Rats, Wistar MeSH
- Streptozocin administration & dosage MeSH
- Valerates administration & dosage pharmacology MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Beta-hydroxy-beta-methyl butyrate (HMB) is a unique product of leucine catabolism with positive effects on protein balance. We have examined the effects of HMB (200 mg/kg/day via osmotic pump for 7 days) on rats with diabetes induced by streptozotocin (STZ, 100 mg/kg intraperitoneally). STZ induced severe diabetes associated with muscle wasting, decreased ATP in the liver, and increased α-ketoglutarate in muscles. In plasma, liver, and muscles increased branched-chain amino acids (BCAAs; valine, isoleucine, and leucine) and decreased serine. The decreases in mass and protein content of muscles and increases in BCAA concentration were more pronounced in extensor digitorum longus (fast-twitch muscle) than in soleus muscle (slow-twitch muscle). HMB infusion to STZ-treated animals increased glycemia and serine in the liver, decreased BCAAs in plasma and muscles, and decreased ATP in the liver and muscles. The effects of HMB on the weight and protein content of tissues were nonsignificant. We concluded that fast-twitch muscles are more sensitive to STZ than slow-twitch muscles and that HMB administration to STZ-treated rats has dual effects. Adjustments of BCAA concentrations in plasma and muscles and serine in the liver can be considered beneficial, whereas the increased glycemia and decreased ATP concentrations in the liver and muscles are detrimental.
Department of Physiology Faculty of Medicine Charles University 500 38 Hradec Králové Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21026478
- 003
- CZ-PrNML
- 005
- 20211026132857.0
- 007
- ta
- 008
- 211013s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/biom10111475 $2 doi
- 035 __
- $a (PubMed)33114049
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Holeček, Milan $u Department of Physiology, Faculty of Medicine, Charles University, 500 38 Hradec Králové, Czech Republic
- 245 10
- $a Dual Effects of Beta-Hydroxy-Beta-Methylbutyrate (HMB) on Amino Acid, Energy, and Protein Metabolism in the Liver and Muscles of Rats with Streptozotocin-Induced Type 1 Diabetes / $c M. Holeček, M. Vodeničarovová, R. Fingrová
- 520 9_
- $a Beta-hydroxy-beta-methyl butyrate (HMB) is a unique product of leucine catabolism with positive effects on protein balance. We have examined the effects of HMB (200 mg/kg/day via osmotic pump for 7 days) on rats with diabetes induced by streptozotocin (STZ, 100 mg/kg intraperitoneally). STZ induced severe diabetes associated with muscle wasting, decreased ATP in the liver, and increased α-ketoglutarate in muscles. In plasma, liver, and muscles increased branched-chain amino acids (BCAAs; valine, isoleucine, and leucine) and decreased serine. The decreases in mass and protein content of muscles and increases in BCAA concentration were more pronounced in extensor digitorum longus (fast-twitch muscle) than in soleus muscle (slow-twitch muscle). HMB infusion to STZ-treated animals increased glycemia and serine in the liver, decreased BCAAs in plasma and muscles, and decreased ATP in the liver and muscles. The effects of HMB on the weight and protein content of tissues were nonsignificant. We concluded that fast-twitch muscles are more sensitive to STZ than slow-twitch muscles and that HMB administration to STZ-treated rats has dual effects. Adjustments of BCAA concentrations in plasma and muscles and serine in the liver can be considered beneficial, whereas the increased glycemia and decreased ATP concentrations in the liver and muscles are detrimental.
- 650 _2
- $a aminokyseliny $x aplikace a dávkování $x farmakologie $7 D000596
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a diabetes mellitus 1. typu $x chemicky indukované $x farmakoterapie $x metabolismus $7 D003922
- 650 _2
- $a injekce intraperitoneální $7 D007274
- 650 _2
- $a injekce subkutánní $7 D007279
- 650 _2
- $a játra $x účinky léků $x metabolismus $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a kosterní svaly $x účinky léků $x metabolismus $7 D018482
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a streptozocin $x aplikace a dávkování $7 D013311
- 650 _2
- $a valeráty $x aplikace a dávkování $x farmakologie $7 D014631
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vodeničarovová, Melita $u Department of Physiology, Faculty of Medicine, Charles University, 500 38 Hradec Králové, Czech Republic
- 700 1_
- $a Fingrová, Radana $u Department of Physiology, Faculty of Medicine, Charles University, 500 38 Hradec Králové, Czech Republic
- 773 0_
- $w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 10, č. 11 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33114049 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026132903 $b ABA008
- 999 __
- $a ok $b bmc $g 1715257 $s 1146985
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 10 $c 11 $e 20201023 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
- GRA __
- $a PROGRES Q40/02 $p Charles University
- LZP __
- $a Pubmed-20211013